A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies

NCT03926143 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Due to strategic company decisions, the development of anetumab ravtansine was stopped.

Conditions

Interventions

Sponsor

Bayer